BMY vs HZO · P/E 17, rev $24.46B vs rev $2.31B
Bristol-Myers Squibb Company (BMY) versus MarineMax Inc (HZO) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
MarineMax Inc (HZO) is a specialty retail company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported HZO revenue for 2025-09-30 was $2.31B. Net income was -$30.8M. HZO currently screens at market cap $729.1M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. HZO currently screens at market cap $729.1M.
Not investment advice. Open the BMY and HZO stock pages for the full models.
Not investment advice.